LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 88 filers reported holding LEXICON PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $438,000 | -44.7% | 219,311 | -46.0% | 0.01% | -50.0% |
| Q1 2020 | $792,000 | -48.3% | 406,138 | +10.0% | 0.01% | -33.3% |
| Q4 2019 | $1,532,000 | -12.9% | 369,243 | -36.8% | 0.02% | -31.8% |
| Q3 2019 | $1,759,000 | +186.5% | 584,304 | +498.4% | 0.02% | +175.0% |
| Q2 2019 | $614,000 | -34.2% | 97,642 | -41.8% | 0.01% | -38.5% |
| Q1 2019 | $933,000 | -43.1% | 167,765 | -32.1% | 0.01% | -55.2% |
| Q4 2018 | $1,641,000 | -11.2% | 247,090 | +42.6% | 0.03% | +11.5% |
| Q3 2018 | $1,849,000 | -9.9% | 173,330 | +1.3% | 0.03% | -18.8% |
| Q2 2018 | $2,053,000 | +167.3% | 171,107 | +90.9% | 0.03% | +146.2% |
| Q1 2018 | $768,000 | -46.1% | 89,644 | -37.8% | 0.01% | -48.0% |
| Q4 2017 | $1,424,000 | +530.1% | 144,139 | +413.8% | 0.02% | +525.0% |
| Q2 2015 | $226,000 | – | 28,054 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $25,366,000 | 100.00% |
| Artal Group S.A. | 71,178,364 | $417,817,000 | 7.38% |
| BVF INC/IL | 8,394,000 | $49,273,000 | 1.85% |
| Boothe Investment Group, Inc. | 435,939 | $2,559,000 | 1.49% |
| Campbell & CO Investment Adviser LLC | 103,100 | $605,000 | 0.37% |
| NEA Management Company, LLC | 2,382,286 | $13,984,000 | 0.31% |
| PINNACLE ASSOCIATES LTD | 2,167,172 | $12,721,000 | 0.24% |
| Eversept Partners, LP | 410,593 | $2,410,181 | 0.18% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $210,000 | 0.12% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 66,299 | $389,000 | 0.08% |